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INTRODUCTION 
During pregnancy, mammary gland development may be divided into 
two phases (mammogenesis and lactogenesis)• The proliferation of the 
lobuloalveolar system which occurs during most of pregnancy is defined 
as mammogenesis. The increase in cell number near term and the 
differentiation of these cells into competent secretory daughter cells 
is defined as lactogenesis. 
During early and mid-pregnancy, there is a steady increase in the 
number of parenchymal cells which occurs at the expense of the fat pad 
portion of the gland (Harkness and Harkness, 1956; Paape and Sinha, 
1971). This increase in cell number has been correlated with the 
development of alveolar structure (Dilley, 1971). Since the DNA content 
of mammary parenchymal cell nuclei remains constant (Tucker and Reece, 
1962), cell number can be properly estimated by the DNA content of the 
gland (Griffith and Turner, 1957; Munford, 1963; Nagasawa et al., 1967). 
Near term, mammary gland DNA continues to increase and represents 
an increase in the number of parenchymal cells per alveolus (Munford, 
1953). Dramatic ultrastructural and biochemical changes accompany this 
increase in cell number (Weilings, 1969). These changes represent a 
transition from the non-secretory to the secretory state, and are 
associated with the initiation of milk secretion. An increase in RNA 
is characteristic of this phase of mammary gland development. This is 
associated with an hypertrophy of the rough endoplasmic reticulum 
(Banerjee and Banerjee, 1971) and can be used to evaluate the development 
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of secretory capability. 
Studies on the hormonal regulation of mammary gland development in 
vivo have been reviewed by several authors in recent years (Cowie, 1969; 
Turner, 1970; Denamur, 1971; Kuhn, 1971; Ceriani, 1974; Meites, 1974). 
Conclusions based on in vitro studies have also been reviewed (Turkington, 
1972; Turkington et al., 1973; Topper, 1970, Topper and Green, 1971; 
Porter, 1974). 
The role of estrogen and progesterone in stimulating extensive 
lobuloalveolar growth during early and mid-pregnancy has been clearly 
defined in experimental mammogenesis (Moon et al., 1959). However, the 
hormonal events which signal the time at which lactogenesis should occur 
are less clearly understood. Kuhn (1971) has defined two basic concepts 
which permeate studies on lactogenesis. One is that lactogenesis is 
follows the withdrawal of the ovarian or placental steroids which promote 
growth, but restrain the onset of lactation. The other is that 
lactogenesis is the response to a positive stimulus in the form of 
increased secretion of pituitary hormones. The work of Liggins et al. 
(1973) on the mechanism of the initiation of parturition in the ewe 
has added a third perspective. There is sufficient evidence in the 
sheep (Drost and Holm, 1968; Basset and Thorburn, 1969; Liggins, 1973) 
and goat (Currie et al., 1973) to implicate fetal adrenal activity near-
term as the event which precipitates the multiple hormonal changes 
leading to parturition. Increased fetal adrenal activity near term has 
also been described in humans (Smith and Shearman, 1972), dogs (Jackson 
et al., 1973), pigs (Dvorak, 1972), guinea pigs (Jones, 1974) and rats 
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(Cohen, 1973; Milkovic et al., 1973). The signal which directs and 
coordinates the multifactorial changes leading to parturition may also 
lead to lactogenesis. Glucocorticoids have been implicated in the 
initiation of milk secretion both in vivo (Talwalker et al., 1961; 
Davis and Liu, 1969; Ferreri and Griffith, 1969; Kumaresan et al., 
1967) and in vitro (Banerjee et al., 1971). One of the aims of this 
investigation is to examine the possibility that glucocorticoids of 
fetal origin may be involved in the initiation of milk secretion. The 
role of maternal adrenal activity near term is also considered, because a 
reciprocal relationship between the maternal and fetal hypophyseal-
adrenal axes has been described in the rat (Jones et al., 1953; 
Christiansen and Chester Jones, 1957). 
In order to evaluate fetal and maternal adrenal involvement in 
mammary gland development near term, the effect of hypophysectomy, 
adrenalectomy, pup removal and treatment with hydrocortisone acetate 
on mammary gland DNA and RNA content was determined. The effect of 
pup removal on maternal adrenal secretion rate and plasma corticosterone 
levels was also evaluated. 
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LITERATURE REVIEW 
Stages in Maimary Gland Development 
The first anlage of the mammary gland (the mammary crest) appears 
as a thickening of ectoderm on the ventral surface of the embryo. 
Proliferation and constriction of this ectoderm results in the 
formation of mammary buds. These buds "sink" in to the mesenchyme, 
but remain connected to the ectoderm by a cylindrical shaft of ecto­
dermal cells. The buds elongate to form a primary sprout which will 
eventually become the milk duct. Secondary sprouts form and are the 
anlagen of the duct system and glandular tissue (Raynaud, 1971). 
After birth and until day 22, the rat mammary gland increases in area 
at the same rate as body surface area (Cowie, 1949). From the time 
of weaning until the onset of puberty, DMA increases and mammary gland 
area increases at a rate 3.5 times greater than body surface area 
(Sinha and Tucker, 1966). Pubertal growth of the mammary gland 
represents an increase in the rudimentary duct systan (Nagasawa et al., 
1967) and an increase in adipose and connective tissue portions of the 
gland (Paape and Sinha, 1971). 
During pregnancy, there is a steady increase in the volume of 
glandular tissue (Munford 1963) and the DNA content of the gland 
(Griffith and Turner, 1961, Tucker and Reece, 1963). Growth of the 
mammary gland during pregnancy, unlike pubertal growth, is reflected 
only in the parenchymal portion of the gland and occurs at the expense 
of the fat pad portion (Harkness and Harkness, 1956; Paape and Sinha, 
1971). 
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It is upon the fully developed lobuloalveolar gland of mid- and 
late pregnancy that the essential hormones of lactogenesis are competent 
to act. Near term, the transition from non-1actating to lactating tissue 
occurs. There is a striking fall in the number of alveoli per unit area, 
a corresponding rise in alveolar diameter, and a two-fold increase in the 
number of nuclei in the average alveolar cross section (Munford, 1963). 
Accompanying the increase in cellularity, there are ultrastructural and 
biochemical changes in the mammary parenchymal cells. 
The ultrastructural changes include (Weilings, 1969; Holmann and 
Verley, 1972): 
1. An increase in mitochondrial volume; 
2. a rapid increase in the extensiveness of the endoplasmic 
reticulum; 
3. an hypertrophy and supranuclear localization of the Golgi 
apparatus; 
4. an increase in the number of cytoplasmic droplets and granules, 
and a migration of these inclusions to the apical surface of the cell; 
5. an increase in the number of microvilli. 
The biochemical changes include (Denamur, 1969; Baldwin and 
Milligan, 1966; Kuhn, 1972): 
1. An increase in the RNA content of the cell; 
2. an increase in the activity of citrate cleavage enzyme, fatty 
acid synthetase, glycerol kinase, glycerol-P-dehydrogenase, aspartic and 
glutamic acid amino transferase, and UDPG pyrophosphorylase; 
3. an increase in the synthesis of a- and 6- casein, g-lactooiobulin. 
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fatty acids and lactose; 
4. an increase in the transport of milk serum albumin, immuno­
globulin, salts, glucose, amino acids and fatty acids from the plasma 
to the mammary parenchymal eel 1. 
The Hormonal Control of Pregnancy and Parturition 
Control of 1uteal function 
Selye et al. (1935) described the essentiality of the ovary in the 
maintenance of pregnancy in the rat, and postulated that the placenta 
determined the length of gestation either by an effect on the corpus 
luteum or by its own progestin secretion. Subsequent investigations 
have elaborated upon the endocrine interrelationships which govern 
pregnancy, but the basic understanding has remained unchanged since the 
time of Selye. 
In the estrous cycle of the rat (Schwartz, 1969), a new set of 
follicles begins growing or. the day of estrus under the influence of 
FSH. Follicular growth continues during metestrus under stimulation 
of FSH and low levels of LH. Pituitary secretion of LH during diestrus 
stimulates the secretion of large amounts of estrogen. On the day of 
proestrus, the ovulatory surge of LH occurs. LH begins to act on the 
ovary to bring about pre-ovulatory swelling of the follicle, a decrease 
in estrogen secretion and an increase in progesterone secretion. 
Mating behavior is elicited and ovulation takes place after midnight 
of proestrus. The estrous cycle must be interrupted if pregnancy is 
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to continue. Spies et al. (1971) suggested that stimulation of the 
cervix during coitus causes the reflex release of prolactin which is 
luteotrophic in the rat. This suggestion is based on the observation 
that severence of the pelvic nerve to the cervix results in failure 
of the blastocyst to implant unless the animal is treated with pro­
lactin. The presence of the conceptus in the uterus may inhibit the 
luteolytic action of the uterus, as in the sheep (Anderson et al., 
1969) and/or may induce uterine luteotrophic activity as does 
decidualization of the rat uterus (Gibori et al., 1974). 
The role of prolactin during pregnancy has been described by many 
authors. Plasma prolactin levels are relatively higher during the first 
few days of pregnancy than they are during most of the estrous cycle (Bast 
and Melampy, 1972), and often show an erratic pattern of change during 
this period (Morishige et al., 1973). Prolactin has been repeatedly 
described as the luteotrophic hormone of early pregnancy and pseudo-
pregnancy in the rat (Takayama and Greenwald, 1973). Administration 
of ergocornine free base (Morishige and Rothchild, 1974) or ergocryptine 
mesylate (Ford and Yoshinaga, 1975a) which suppress prolactin release 
from day 1 to day 8 of pregnancy results in a decline in circulating 
progesterone levels and uniformly induces abortion. After day 8, 
prolactin is no longer essential for luteal maintenance and treatment 
with ergocornine or ergocryptine does not result in abortion. Prior to 
complete control of luteal function by the placenta on day 11, 
hypophysectomy results in abortion of the fetuses (Pepe and Rothchild, 
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1972). It has been suggested that luteal maintenance from day 8 to 
day 11 is a function of LH secretion. Serum LH concentrations during 
the first eleven days of pregnancy is distinctly higher than concen­
trations between days 13 and 19 (Morishige et al., 1973). Administration 
of LH antiserum from day 8 to day 11 results in abortion, but it does 
not induce abortion prior to day 8 or after day 11 (Ford and Yoshinaga, 
1975b; Morishige and Rothchild, 1974). 
Placental control of luteal function after day 12 may be attributed 
to the prolactin-like properties of rat chorionic mammotrophin (Ray 
et al., 1955), and is evidenced by failure of hypophysectomy after day 
12 to induce abortion (Selye et al., 1935). The role of rat chorionic 
mammotrophin (RCM) in pregnancy and mammary gland development has 
recently been reviewed by Matthias (1974). In situ production of a 
progestin by the rat placenta has also been described (Chan and Leathern, 
1975). This may account for failure of ovariectomy after day 18 to induce 
abortion, but does not offer sufficient progestational support prior to 
day 18. 
Changes in ovarian secretion near term 
The progestational potency of ovarian secretions during pregnancy 
is reflected in the ratio of progesterone to its inactive metabolite, 
20a hydroxy pregn-4en-3one (Fajer and Barraclough, 1957) and in changes 
in estrogen secretion (Yoshinaga et al., 1969). Progesterone levels rise 
to a peak during early pregnancy while 20a hydroxy pregn-4en-3one 
(20a0HP) levels decrease. At mid-gestation, there is a second rise in 
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plasma progesterone accompanied by an increase in ZOctOHP. Between 
days 19 and 21, progesterone levels drop and there is an increase in 
peripheral levels of 20a0HP (Wiest et al., 1968). 
An increase in LH levels near term has been correlated with an 
increase in the activity of 20a hydroxy steroid dehydrogenase (Bast 
and Melampy, 1972), and changes in serum progesterone levels are 
inversely related to those in serum LH from day 11 to term (Morishige 
et al., 1973). Hypophysectomy after day 12 delays the increase in the 
activity of 20a hydroxy steriod dehydrogenase (20a0HSDH) and treatment 
with LH restores enzyme activity to normal (Wiest et al., 1968). 
Hypophysectomy also prevents the rapid fall in progesterone which 
normally precedes parturition (Pepe and Rothchild, 1972). Hence, an 
increase in LH near term may direct progesterone catabolism to 20a0HP 
in the ovary as a mechanism for the prompt withdrawal of progesterone. 
Except for the pre-implantation surge in 173 estradiol, there is 
no significant change in estradiol levels until day IS of pregnancy. 
From day 18 through term, there is a steady increase in estradiol 
levels (Yoshinaga et al.. 1969). It has been suggested (Waynforth and 
Robertson, 1972) that the increase in estradiol is also controlled by 
pituitary gonadotrophins and represents the advent of a post-partum 
ovulation. Hypophysectomy abolishes the increase in the estradiol 
content of ovarian venous blood and the extraluteal component of the 
ovary between days 16 and 21. The increase in estradiol coincides with 
an increase in PSFg^ (Labhsetwar and Watson, 1974). PGFg^ has been 
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found to cause degeneration of the corpora lutea of pregnancy and induces 
the formation of a fresh set of corpora lutea (Labhsetwar, 1972). 
Fetal adrenal activity 
The role of fetal adrenal activity in the precipitation of the 
endocrine events which precede parturition has been most comprehensively 
studied in the sheep, and has been recently reviewed by Liggins et al. 
(1973). The observation that gestation could be prolonged in ewes 
after fetal adrenalectomy (Drost and Holm, 1968) has directed attention 
to fetal physiology and its possible control of parturition. 
The pituitary-adrenal system of the fetal lamb becomes active in 
late gestation. The increase in ACTH,which is noted after 140 days 
gestational age (Alexander et al., 1971), has been attributed to hypo­
thalamic maturation (Liggins et al., 1973) or fetal asphyxia (Dawes, 
1973). Before 130 days gestational age, fetal plasma levels of 
corticosteroids are low (Basset and Thorburn, 1969) and then increase 
markedly near term (Drost et al., 1973). The increase in secretory 
activity of the adrenal cortex coincides with morphological changes in 
the adrenal gland near term (Alexander et al., 1968). It has been 
suggested that ACTH is responsible for an increase in the activity 
of an lis hydroxylase enzyme, which, in turn, enhances Cortisol 
synthesis (Anderson et al., 1973). 
The rise in fetal adrenal corticosteroids precedes all the other 
hormonal changes seen in the maternal plasma just prior to parturition. 
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It may be responsible for the decrease in progesterone and the increase 
in estrogen which is accompanied by an increase in (Currie et al., 
1973). Infusion of ACTH to fetal lambs at gestational ages of 88 to 
129 days (Liggins, 1968) or dexamethasone (Liggins, 1969) results in 
premature parturition. Liggins (1973) has proposed the following model 
to describe the initiation of parturition in the sheep. Fetal Cortisol, 
by some unknown means, stimulates release of unconjugated estrogens 
from the placenta and causes a fall in the secretion of progesterone. 
The effect of estrogen in the presence of progesterone is to stimulate 
the potential for synthesis of PGFg^ in the maternal placenta. The 
local action of progesterone is to block the release of PGFgg. The 
net effect of changes in the estrogen to progesterone ratio preceding 
parturition is the release of large amounts of PGFg^ which reach the 
myometrium by an unknown, but direct route. PGFg^^ may have a direct 
oxytocic effect and may increase myometrial sensitivity to oxytocin. 
There are striking similarities between the changes in the hormonal 
status of the dam which precedes parturition in the rat and those which 
precede parturition in the sheep. However, in the rat, the control of 
estrogen and progestin secretion must be exerted on the ovary and not 
the placenta. Uterine vein PGFg^ does increase near term (Labhsetwar 
and Watson, 1974). This increase coincides with a decrease in 
progesterone and an increase in 173 estradiol, and has been shown to 
be luteolytic in the rat (Labhsetwar, 1972). The advent of fetal 
adrenal activity near term has been described in the rat, but its role 
is not as clearly defined as it is in the sheep. 
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The adrenal primordium of the rat is recognizable on the 13th day 
of intrauterine life, and is a discrete organ by the 15th day (Bloch, 
1958). It increases in weight from day 16 to day 20 and reaches a 
peak of activity between days 18 and 20 (Cost, 1966). Fetal plasma 
corticosterone levels are highest between days 19 and 20 (Cohen, 1973). 
Fetal adrenals are 6 times more sensitive to ACTH stimulation than are 
maternal adrenals (Milkovic and Milkovic, 1962). Stimulation of 
maternal adrenals by cold stress or ACTH results in a decrease in 
fetal adrenal activity indicating that corticosteroids may pass the 
placental barrier, but that ACTH may not (Jones et al., 1953). The 
reactiveness of the fetal adrenal cortex has been shown to be dependent 
upon fetal adrenocorticotrophic activity. Since high maternal plasma 
levels of corticosterone, stimulated by ACTH tumor implants, are 
paralleled by markedly lighter fetal adrenal weights after the 18th 
day but not on the 17th day, fetal adrenocorticotrophic activity is 
said to begin between the 17th and 18th day of intrauterine life 
(Milkovic et al., 1973). The responsiveness of the fetal pituitary 
adrenal axis to changes in glucocorticoid levels in the dam has been 
demonstrated by a number of authors. Adrenalectomy of the dam results 
in an increase in fetal adrenal weight (Knobil and Briggs, 1955) and 
the survival of pregnant adrenalectomized rats is longer than survival 
of non-pregnant adrenalectomized rats (Davis and Plotz, 1954). 
Treatment of adrenalectomized dams with cortisone acetate (Davis and 
Plotz, 1954) prevents fetal adrenal hypertrophy. The enlargement of 
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fetal adrenals after maternal adrenalectomy is due to increased activity 
of the fetal hypophysis since it does not occur when the fetuses are 
decapitated (Christianson and Chester Jones, 1957). It is not dependent 
upon the maternal hypophysis since hypophysectomy of adrenalectomized 
dams does not prevent fetal adrenal hypertrophy (Christianson and 
Chester Jones, 1957). 
Hormonal Control of Lactogenesis 
In vivo studies 
There is substantial evidence to implicate the hormonal changes 
which occur prior to parturition as being essential for lactogenesis. 
Ovariectomy after mid-pregnancy, which represents the experimental 
withdrawal of progesterone, results in a marked increase in protein phos­
phorus in the mammary gland (Kuhn, 1972), an increase in total RNA, an 
increase in the RNA to DMA ratio, and an increase in the heavy polysome 
fraction (Davis et al.- 1972). The increase in each of these indicators of 
lactogenesis is prevented by treatment of the ovariectomized animal 
with progesterone. In the intact pregnant rat, treatment with estradiol 
benzoate and progesterone near term also inhibits the normal increase 
in RNA (Stefaniw, 1971). Although a combination of these steroids 
inhibits the lactogenic response, extensive lobuloalveolar growth 
continues (Meites and Sgouris, 1953), and the DNA content of the gland 
is not affected (Stefaniw, 1971). 
Serum prolactin levels rise near term (Bast and Melampy, 1972; 
14 
Nagasawa and Yanai, 1972). The increase in prolactin is correlated 
with the pre-partum increase in estrogen and decrease in progesterone 
(Denamur, 1971). Furthermore, intrapituitary implants of estrogen 
stimulate prolactin release and the initiation of milk secretion 
(Bruce and Ramirez, 1970). 
An increase in prolactin is not sufficient for lobuloalveolar 
differentiation unless it is accompanied by adrenal cortical activity 
(Ben-David et al., 1971). Similarly, experimental withdrawal of 
progesterone, by ovariectomy after mid-pregnancy does not result in 
lactogenesis in the adrenalectomized rat (Davis and Liu, 1969). The 
effect of glucocorticoids, in turn, is a function of the endocrine 
status of the dam (Ahren and Jacobson, 1957). During late pregnancy, 
treatment with hydrocortisone acetate results in an increase in RNA, 
indicative of lactogenesis (Ferreri and Griffith, 1969), and is 
capable of inducing mammary secretions (Talwalker et al., 1961). During 
early and mid-pregnancy: treatment with hydrocortisone acetate does not 
result in this increase. 
The hormonal interrelationships which may affect lactogenesis are 
represented schematically in Figure 1 and Figure 2 and can be summarized 
as follows (Meites, 1954; Meites, 1974; Kuhn, 1971): 
1. The high ratio of progesterone to estrogen which prevails during 
early and mid-pregnancy stimulates intense lobuloalveolar growth and 
thereby renders the mammary gland refractory to lactogenic stimulation. 
2. Prolactin and/or adrenal steroids are produced in inadequate 
amounts during most of pregnancy. 
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RCM 
(days 12-20) 
PROLACTIN 
(days 1-8) (days 8-12) 
OVARY 
E+P 
' LOW LEVELS 
OF ACTIVE GLUCO-
LOW LEVELS 
OF PROLACTIN 
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LOBULOALVEOLAR GROWTH 
CORTICOIDS 
! ' 
MAMMARY GLAND 
REFRACTORY TO 
LACTOGENIC STIMULATION BY 
PROLACTIN OR GLUCOCORTICOIDS 
t 
NO LACTOGENESIS 
Fig. 1. Hormonal factors inhibiting lactogenesis during early and 
mid-pregnancy. 
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OF PROLACTIN 
LACTOGENIC STIMULATION BY 
PROLACTIN OR GLuCOCûRiICOIDS 
LACTOGENESIS 
Fig. 2. Hormonal factors precipitating lactogenesis near term 
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3. The fall in progesterone near term and the increase in estrogen 
renders the gland more sensitive to lactogenic stimulation. 
4. The secretion of prolactin increases near term due to direct 
stimulation by estrogen and the withdrawal of progesterone inhibition. 
5. There is an increase in the level of biologically active 
glucocorticoids. 
6. Once the mammary gland has developed sufficient alveoli, it 
responds to stimulation by prolactin and an adrenal cortical steroid. 
7. Lactogenesis results from increased secretion of prolactin and 
adrenal steroids, which are themselves liberated and allowed to act by 
the withdrawal of inhibitory steroids. 
In vitro studies 
A proposed mechanism of hormone action in lactogenesis has been 
described on the basis of biochemical and ultrastructural changes which 
occur in pregnant mouse mammary gland expiants cultured in hormonal1y 
defined media. Many of the investigations in this area of research 
have been reviewed by Turkington et al. (1973) and Topper (1970). 
Mills and Topper (1970) have reported the following ultrastructural 
observations. Expiants cultured in insulin and hydrocortisone (IF 
medium) for 96 hours contain more epithelial cells and less adipose 
tissue than zero time samples taken from freshly killed fifteen day 
pregnant mice. There is an increase in the number of alveoli within 
the expiant as well as a two-fold increase in the average number of 
cells per alveolar cross section. The lumina of the alveoli are wider 
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and there is a slight increase in the amount of rough endoplasmic 
reticulum (RER) and the Golgi apparatus (G). There is no change in the 
polarity of cellular organelles. Expiants placed in a second incubation 
medium containing insulin plus hydrocortisone plus prolactin (IFF medium) 
for up to 96 hours contain less adipose than expiants after the first 
incubation. The alveoli are still larger and contain even more cells per 
alveolar cross sectional area. The alveoli lumina are greatly distended 
and filled with lipid and protein. The cells are larger and show a 
polarity of cellular organelles. The bulk of the RER is located in the 
basal portion of the cell along with the nucleus. The Golgi is supra­
nuclear and filled with secretory proteins. From these observations. 
Topper and Green (1971) have suggested the following sequence of events: 
1. Insulin promotes the formation of a pair of daughter cells 
from each alveolar cell. 
2. Hydrocortisone, in the presence of insulin, promotes the 
formation of an extensive RER system; but it has no effect on the number 
of daughter cells. 
3. Insulin and prolactin stimulate synthesis of certain secretory 
proteins by the newly differentiated cells. 
Turkington's group has monitored changes in several biochemical 
parameters upon incubation with insulin, hydrocortisone and prolactin. 
These studies provide evidence for the essentiality of cell division 
prior to functional differentiation, and describe a possible model for 
the mechanism of hormone action in effecting gene expression of a 
unique mammary gland function. 
After 96 hours of incubation in IF medium, mouse mammary gland 
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cells do not produce casein unless prolactin is added. If mitosis 
during the IF incubation period is prevented by the addition of 
colchicine, prolactin does not stimulate casein synthesis (lurkington, 
1968). Similarly, the prolactin induced increase in polyribosomes 
does not occur in a colchicine pre-treated incubation or in the absence 
of previous exposure to IF medium (Turkington and Riddle, 1970). An 
increase in prolactin stimulated phosphorylation of nuclear proteins 
occurs only when the tissue is pre-incubated with I+F (Turkington and 
Riddle. 1969). 
Insulin stimulation of mitotic activity during the first incubation 
period is accompanied by increased phosphorylation of existing nuclear 
proteins, increased RNA polymerase activity, increased RNA synthesis, 
increased nuclear protein synthesis (Turkington and Riddle, 1969), and 
increased DNA synthesis (Turkington et al., 1971). Hence, in these 
studies, insulin-directed DNA synthesis and mitosis is a prerequisite 
for differentiated, prolactin stimulated, mammary gland activity. 
The selective effect of prolactin on gene expression is evidenced 
by the fact that induction of casein and lactalbumin synthesis by 
prolactin is abolished by the incorporation of thymidine analogues 
during the pre-incubation period, whereas synthesis of proteins with a 
more general distribution in cells is not decreased. It has been 
suggested that the genomes for specific milk protein synthesis are 
thymidine rich and more seriously affected by the incorporation of 
thymidine analogues during replication (Turkington et al., 1971). 
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The mechanism by which specific genes are expressed may involve the 
selective phosphorylation of histones under prolactin stimulation, 
which is coupled with RNA and protein synthesis. Prolactin stimulates 
the phosphorylation of specific histone fractions, in contrast to 
insulin stimulation of histone phosphorylation in all fractions 
(Turkington and Riddle, 1969). With respect to phosphorylation of 
histones and activation of subsequent protein synthesis, neither cAMP 
nor adenyl cyclase activity has been found to be rate limiting. Instead, 
protein kinases and cAMP binding proteins seem to be rate limiting. 
Prolactin induces a rapid increase in protein kinase and cAMP binding 
activity (Majumder and Turkington, 1971) which precedes nuclear protein 
phosphorylation and casein synthesis. Figure 3 summarizes the results 
obtained from the in vitro studies cited herein, and describes a 
possible mechanism of hormone action in lactogenesis. 
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Fig. 3. A possible mechanism of hormone action in lactogenesis. 
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METHODS 
Treatment of Animals 
Six adult female rats and one mature male rat of the Sprague-
Dawley strain were placed in large cages for breeding. The presence 
of sperm in a vaginal smear was considered day 1 of pregnancy. 
Pregnant animals were housed individually for the length of gestation, 
and all were given food and tap water ad libitum until day 18 of 
pregnancy. From day 18 to day 22, tap water was replaced by water contain­
ing 5% glucose and 1% NaCl for the hypophysectomized and adrenalectomized 
groups, respectively. Animals continued to be fed ad libitum. 
On the 18th day, animals were either sacrificed or subjected to 
one of four types of surgical manipulation. Half of the animals within 
each of the surgical treatment groups were injected with 250 ug hydro­
cortisone acetate (F), subcutaneously, in a 0.1 ml saline suspension; 
the other half received no hormone therapy. Animals were sacrificed 
by decapitation on day 22, with the exception of the 18 day control 
group. Treatment groups and symbols used to identify them in the rest 
of the text are listed in Table 1. 
Surgical Procedures 
Adrenalectomy was performed under ether anaesthesia according to 
the method described by Zarrow et al. (1964). Two incisions were made on 
the dorso-lateral aspect of the animal, below the last rib. The supra­
renal fat pad was grasped with a curved forceps and the adrenal gland 
Table 1. Treatment groups 
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Group Surgical Hormone Time of 
Symbol Procedure Treatment Sacrifice 
A Adrenalectomy None Day 22 
on day 18 
AF Adrenalectomy 250 yg F daily from Day 22 
on day 18 days 18-21 
H Hypophysectomy None Day 22 
on day 18 
HF Hypophysectomy 250 yg F daily from Day 22 
on day 18 days 18-21 
P Pup removal None Day 22 
on day 18 
PF Pup removal 250 yg F daily from Day 22 
on day 18 days 18-21 
C Sham operation None Day 22 
on day 18 
CF Sham operation 250 yg F daily from Day 22 
on day 18 days 18-21 
E None None Day 18 
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teased free. Upon sacrifice, the aorta and supra-renal fat were 
visually examined for residual adrenal tissue. 
Hypophysectomy was performed by the intra-auricular method, using 
the Hoffman-Reiter Hypophysectomizer stereotaxic device. The ear canal 
was swabbed with 70% ethanol. The pinna was snipped above and below 
the ear canal in order to facilitate positioning of the ear bars. An 
18 gauge, thin walled, wide beveled needle attached to a 10 cc syringe 
was inserted through the right ear canal and guided to a position above 
the sella turcica. The pituitary was removed by aspiration. Upon 
sacrifice, the sella turcica was examined for the presence of residual 
tissue. Reduced adrenal weights were also used as an indication of the 
effectiveness of hypophysectomy. 
Pups were removed according to the method described by Pritchard 
and Huggett (1947). The uterus was exposed by laparotomy on day 18. 
A small incision was made on the mesometrial part of the uterus. The 
fluid-fill ad membranes were perforated and the fetuses were allowed to 
escape through the uterine incision. It was not necessary to suture the 
uterus. 
Mammary Gland Nucleic Acid Analysis 
Preparation of dried fat free tissue (DFFT) 
The six abdominal-inguinal glands were excised; defatted in chloroform 
and methanol (2:1, vlv) for two twelve-hour periods, and in ether for 
two subsequent twelve-hour periods. The jars contained approximately 
25 
50 ml solvent and were kept under constant agitation. After the final 
solvent was decanted, the tissue was allowed to air dry. 
Nucleic acid extraction 
The method used for nucleic acid extraction was that described by 
Schneider (1945) and modified by Ferreri (1971). 
1. Twenty-five mg of dry fat-free tissue suspended in 5 ml of 5% 
trichloro-acetic acid (TCA) in thick walled 15 ml volumetric centrifuge 
tubes was allowed to stand at room temperature until the DFFT became 
saturated and "fell" to the bottom of the tube with gentle tapping. 
2. Samples were covered with glass marbles and placed in a hot 
water bath (90-95°C) for 15 minutes and then transferred to a cold water 
bath. 
3. Samples were centrifuged for 30 minutes, and the supernatant 
was poured into 12 ml volumetric centrifuge tubes. 
4. A second extraction in hot TCA was made on the centrifugate, and 
the supernatant was added to that recovered from the first extraction. 
5. The total volume was brought to 10 ml by the addition of cold 5% 
TCA, transferred to glass storage tubes, and stored at 4°C. 
Colorimetric determination of DMA content 
The method used was that described by Burton (1956) and modified by 
Ferreri (1971). 
1. Diphenylamine reagent was prepared immediately before use. It 
consisted of 1.5 g of reagent grade diphenylamine in 100 ml of A.R. 
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acetic acid and 1.5 ml of concentrated sulfuric acid. Five-tenths ml 
of acetaldehyde (16 mg/ml) was added to the reagent mixture prior to 
its addition to the samples. 
2. One ml of nucleic acid extract or DNA standard was combined 
with 4 ml of diphenyl amine reagent and 1 ml of IN perchloric acid (9 ml 
of 70% perchloric acid in 91 ml of distilled water). 
3. A blank was prepared with 1 ml of 5% TCA, 4 ml of diphenyl amine 
reagent, and 1 ml of IN perchloric acid. 
4. Color was developed after 16 to 20 hours incubation at room 
temperature, and absorbance was measured against the blank at 600 my. 
5. The concentration of DNA in the sample was calculated from a 
least squares estimation of the slope and Y intercept of the standard 
curve (absorbance vs concentration). 
Colorimetric determination of RNA content 
The method used was that described by Mejbaum (1939) and outlined 
in Schneider (1957). 
1. Immediately before use, 1 g of orcinol was added to 100 ml of 
FeClg in HCl (0.5 g of FeClg per 100 ml of concentrated HCl). 
2. Five-tenths ml of nucleic acid extract or 0.5 ml of DNA or RNA 
standard were added to 2.0 ml of 5% TCA. 
3. Orcinol reagent (2.5 ml) was then added to the samples which 
were then placed in a boiling water bath for 20 minutes to develop color. 
4. A blank was prepared with 2.5 ml TCA (5%) and 2.5 ml of orcinol 
reagent. Absorbance was measured against the blank at 660 my. 
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5. Standard curves and least squares estimations of the slopes and 
Y intercepts for both the RNA and DNA standards were made. Corrections 
for absorbance due to DNA were made using those concentrations for the 
unknown samples as previously determined by the Burton method. 
In Vitro Incubation Procedures 
Preparation of incubation medium (Cohen, 1957) 
The following stock solutions were prepared and stored under 
refrigeration: 
1. NaCl (4.5 g/500 ml distilled water) 
2. KCl (1.73 g/150 ml distilled water) 
3. CaCl2'2H0H (2.43 g/150 ml distilled water) 
4. KHgPO^ (3.17 g/150 ml distilled water) 
5. MgS0^*7H0H (5.73 g/150 ml distilled water) 
6. NaHCOg (1.95 g/150 ml distilled water) 
Prior to use; stock solutions were mixed in the following proportions: 
100 parts NaCl 
4 parts KCl 
3 parts CaCl2*2nOK 
1 part HKgPOg 
1 part MgS04-7H0H 
21 parts NaHCOg 
Glucose was added to give a final concentration of 200 mg/100 ml 
incubation medium. ACTH (25 units/mg) was added to half of the 
incubation medium to give a final concentration of 250 milliunits/ml 
incubation medium. 
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Incubation procedure (Saffran et al., 1952; Pritchett, 1973) 
Adrenal glands were rapidly excised from the animal, following 
decapitation and exsanguination, and placed on filter paper moistened 
with incubation medium (minus ACTH). The petri dish containing the 
adrenal glands was kept on ice while the adipose tissue was carefully 
trimmed away from the glands. Each gland was weighed, quartered and 
placed into 25 ml Ehrlenmeyer flasks containing either 2 ml of incubation 
medium minus ACTH or 2 ml of incubation medium plus ACTH. Right and 
left adrenal glands were alternated with respect to ACTH stimulation. 
The flasks were gassed with 95% Og plus 5% COg for 50 seconds, placed 
in a holder designed for the Warburg by Mary McMahon at Iowa State 
University, Ames, Iowa (private communication, 1974), and incubated 
with shaking for 90 minutes at 37°C. At the end of the incubation 
period, the medium was transferred to screw-capped vials and frozen. 
Fluorometric Determination of Corticosterone 
The method used for the determination of corticosterone in plasma 
and in the incubation medium was based on the development of fluorescence 
by ll-hydroxycorticosteroids when exposed to ultraviolet light in 
concentrated sulfuric acid (Mattingly, 1962). The Mattingly method has 
been outlined by Sherrick et al. (1971). Modifications and the reagent 
purification steps used in this investigation have been described by 
Craig (1972). 
1. Dichloromethane purification 
a. Dichloromethane (CHgClg) was allowed to stand over one-tenth 
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its volume of concentrated HgSO^ for three days with 
occasional shaking. 
b. Dichloromethane was washed three times with one-tenth 
its volume on 2N NaOH and then three times with one-tenth 
its volume of distilled water. 
c. Dichloromethane was dried for 24 hours with anhydrous 
sodium sulfate. 
d. Dichloromethane was distilled through a Dufton column. 
The fraction which came over between 40 and 41°C was 
collected. 
2. Ethanol purification 
Ethanol was double distilled in a Dufton column. The 
fraction which came over at 75°G was collected. 
3. Preparation of fluorescence reagent 
Three parts concentrated HgSO^ were slowly added to one part 
purified ethanol kept on ice. 
4. Preparation of corticosterone standards 
Ten mg of corticosterone was dissolved in 5 ml of purified 
ethanol and brought to 100 ml with distilled water. This 
solution was stored under refrigeration and served as the 
stock solution. Aliquots of the stock solution were diluted 
with distilled water to give a series of standards containing 
0.25, 0.5, 1.0, 2.0, and 4.0 ug/ml. 
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Corticosterone determination 
a. Frozen plasma samples or incubation medium were allowed 
to come to room temperature. 
b. Duplicate 0.5 ml aliquots of samples or standards were 
transferred to glass stoppered centrifuge tubes. 
c. Steroids were extracted in 5 ml purified dichloromethane. 
Samples were shaken for sixty seconds, layers allowed to 
separate, and shaken again for thirty seconds. 
d. Samples were centrifuged at 2000 RPM for two minutes. 
The aqueous layer was removed by aspiration. 
e. The remaining extract was washed with 200 yl of O.lN NaOH 
and centrifuged for sixty seconds. NaOH was rapidly removed 
by aspiration to avoid breakdown of the steroid. 
f. Anhydrous sodium sulfate (enough to cover the bottom of 
the tube) was added for ten minutes to dry the extract. 
g. iWQ ml of the NagSv^ dried extract was mixed with 5.0 
of fluorescence reagent by shaking for thirty seconds. 
The mixed samples were centrifuged at 1000 RPM for two 
minutes. The organic (top) layer was removed by aspiration. 
One hour after mixing with the fluorescence reagent 
(step g), fluorescence was read in a Turner model 110 
fluorometer using a Primary 110-813 (47B) filter and a 
Secondary 110-818 (2A-12) filter. 
Micrograms corticosterone/milliliter sample was calculated 
from a standard curve. 
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RESULTS 
For the purpose of clarity in the reporting of results, the data 
have been grouped into the following sections: 
1. Body weights and mammary gland weights 
2. Mammary gland DNA 
3. Mammary gland RNA 
4. Adrenal and ovarian weights 
5. Pup number, pup weights and placental weights 
6. Adrenal secretion rates and plasma corticosterone 
Each section will include a text describing the effect of treatment on 
particular parameters, a table listing the average values and standard 
errors for these parameters, tables of comparisons indicating tests of 
significance, and bar graphs illustrating the comparisons. 
Body Weights and Mammary Gland Weights 
Final body weights (Tables 2 and 3, Fig. 4) 
Final body weights of adrenalectomized (265 g) and pup removal 
(276 g) animals were similar to those of controls (270 g). Body 
weights of hypophysectomized animals (225 g) were lower (P<0.001) 
than those of controls (270 g). Treatment of adrenalectomized, 
hypophysectomized, pup removal or sham operated controls with hydro­
cortisone acetate (F) had no effect on final body weight when compared 
to the respective surgical treatment groups that were not given 
hormone replacement. 
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Table 2. Effect of adrenalectomy, pup removal, hypophysectomy and 
hydrocortisone acetate on final body weight and mammary 
gland dried fat free tissue weight 
Group*(#)b B.W.c s.e.d DFFT® s.e. 
A (9) 265 12.0 568.23 36.04 
AF (10) 276 . 5.7 675.52 37.26 
P (9) 257 6.3 618.56 24.40 
PF (9) 243 6.3 668.75 43.61 
H (10) 225 5.9 426.92 16.98 
HF (9) 216 6.6 472.40 13.71 
C (10) 270 9.2 688.37 29.08 
CF (10) 260 8.4 730.04 46.42 
^Group = symbol used corresponds to treatment described in 
Table 1. 
= number of animals included in the group. 
^B.W. = final body weight (g). 
~s.e. = standard error. 
®DFFT = mammary gland dried fat free tissue weight (mg). 
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Table 3. Statistical comparisons of body weights using t-test 
Groups Difference 
compared between means Significance 
A and AF n not significant 
P and PF 14 not significant 
H and HF 9 not significant 
C and CF 10 not significant 
C and A 5 not significant 
C and AF 6 not significant 
C and P 13 not significant 
C and PF 27 * significant (P<0.05) 
C and H 45 * significant {P<0.001) 
C and HF 54 * significant {P<0.001) 
Fig. 4. Body weights 
35 
Mammary gland dried fat-free tissue weights (Tables 2 and 4, Figure 5) 
Mammary gland dried fat free tissue weights (MG-DFFT) of 
adrenalectomized (568.23 mg) and hypophysectomized (426.92 mg) animals 
were significantly lower (P<0.02 and P<0.001, respectively) than those 
of controls (688.37 mg). MG-DFFT of pup removal animals (618.56 mg) 
was similar to MG-DFFT of the controls (688.37 mg). MG-DFFT's of F 
treated adrenalectomized (675.52 mg) and F treated hypophysectomized 
(472.40 mg) animals were greater (P<0.005) than the MG-DFFT's of the 
corresponding animals that did not receive F treatment. In the case of 
the F treated adrenalectomized animals, MG-DFFT was restored to the 
control level. In the case of the F treated hypophysectomized animal, 
MG-DFFT remained significantly lower (P<0.001) than the control value. 
MG-DFFT's of F treated pup removal (668.75 mg) and F treated sham 
operated (730.04 mg) animals were similar to the MG-DFFT's of the 
corresponding non-treated surgical groups. 
Mammary Gland DNA 
DMA on a per mg MG-DFFT basis (Tables 5 and 6, Fig. 6) 
The average ug/DNA/mgMG-DFFT values of adrenalectomized (37.03), 
hypophysectomized (40.81) and pup removal (33.76) animals were 
significantly higher (P<0.001, P<0.001, P<0.01, respectively) than 
those of controls (27.93). Average ug/DNA/mgMG-DFFT values of F 
treated adrenalectomized (31.42), F treated hypophysectomized (36.50) 
and F treated pup rénovai (30.87) animals were significantly lower 
(P<0.02, P<0.01, P<0.05, respectively) than those of similarly operated 
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Table 4. Statistical comparisons of mammary gland dried fat free 
tissue weights using t-test 
Groups 
compared 
Di fference 
between means Significance 
A and AF 107.19 * approaching 
significance (P<0.05) 
P and PF 50.19 not significant 
H and HF 45.48 * approaching 
significance (P<0.05) 
C and CF 41.67 not significant 
C and A 120.14 * significant (P<0.02) 
C and AF 12.95 not significant 
C and P 69.81 not significant 
C and PF 19.62 not significant 
C and H 261.45 * significant (P<0.001) 
C and HF 215.97 * significant (P<0.001) 
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Table 5. Effect of adrenalectomy, pup removal, hypophysectomy and 
hydrocortisone acetate on mammary gland DNA content 
uqDNA Total 
Group (#) mgDFFT s.e. mgDNA s.e. 
A (9) 37.03 1.69 20.61 0.60 
AF (10) 31.42 1.05 20.96 0.71 
P (9) 33.76 0.91 20.78 0.70 
PF (9) 30.87 1.15 20.39 0.97 
H (10) 40.81 0.75 17.42 0.77 
HF (9) 36.50 1.07 17.23 0.59 
C (10) 27.93 1.22 19.02 0.71 
CF (10) 26.93 1.36 19.21 0.78 
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Table 6. Statistical comparisions of mammary gland DNA expressed 
as ugDNA/mgDFFT using t-test 
Groups 
compared 
Difference 
between means Significance 
A and AF 5.61 * significant (P<0.02) 
P and PF 2.89 * approaches significance 
(P<0.05) 
H and HF 4.31 * significant (P<0.01) 
C and CF 1.00 not significant 
C and A 9.10 * significant (P<0.001) 
C and AF 3.49 * significant (P<0.05) 
C and P 5.83 * significant (P<0.01) 
C and PF 2.94 not significant 
C and H 12.88 * significant (P<0.001) 
C and HF 8.57 * significant (P<0.001) 
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animals that did not receive F treatment. F treatment of the sham operated 
control resulted in a ugDNA/mgMG-DFFT (26.93) which was not significantly 
different from that of the control (27.93). F treatment of pup removal 
animals restored ugDNA/mgMG-DFFT to the control level. F treatment of 
hypophysectomized animals or F treatment of adrenalectomized animals did 
not completely restore ugDNA/mgMG-DFFT to the control level. 
Total mammary gland DNA (Tables 5 and 7, Fig. 7) 
No statistically significant differences were observed in any of 
the planned comparisons made (Table 7). However, the lower total 
mammary gland DNA of hypophysectomized (17.42 mg) and F treated 
hypophysectomized (17.23 mg) animals may have been biologically different 
from that control (19.02), and is statistically different from the 
total mammary gland DNA of adrenalectomized (20.61 mg), F treated 
adrenalectomized (20.96 mg), pup removal (20.78 mg) and F treated pup 
removal (20.39 mg) animals (Fig. 7). 
Mammary Gland RNA 
Total mammary gland RNA (Tables 8 and 9, Fig. 8) 
Total mammary gland RNA (MG-RNA) of adrenalectomized (39.47 mg) 
and pup removal (44.37 mg) animals was not significantly different 
from that of sham operated controls (39.47 mg). MG-RNA of hypophysecto­
mized animals (25.86 mg) was lower (P<0.001) than MG-RNA of controls. 
MG-RNA of F treated adrenalectomized animals (47.02 mg) and F treated 
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Table 7. Statistical comparisons of total DNA content expressed in 
mg using t-test 
Groups Differences 
compared between means Significance 
A and AF 0.35 not significant 
P and PF 0.39 not significant 
H and HF 0.19 not significant 
C and CF 0.19 not significant 
C and A 1.59 not significant 
C and AF 1.94 not significant 
C and P 1.76 not significant 
C and PF 1.37 not significant 
C and H 1.60 not significant 
C and HF 1.79 not significant 
43 
22 
rwxwvi KVWWVI IWNWVt 
A AF P PF H HF C CF 
GROUP 
Fig. 7. Total DNA content of the six abdominal-inguinal mammary glands 
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Table 8. Effect of adrenalectomy, pup removal, hypophysectomy and 
hydrocortisone acetate on mammary gland RNA content 
Total 
Group (#) mgRNA s.e. RNA:DNA s.e. 
A (9) 39.47 2.41 1.91 0.13 
AF (10) 47.02 2.70 2.25 0.11 
P (9) 44.37 2.19 2.13 0.07 
PF (9) 47.62 8.82 2.33 0.09 
H (10) 25.86 0.83 1.56 0.05 
HF (9) 30.42 1.40 1.78 0.08 
C (10) 39.47 3.41 2.27 0.11 
CF (10) 42.61 1.31 2.48 0.16 
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Table 9. Statistical comparisons of total mammary gland RNA content 
expressed in mg 
Groups Di fference 
compared between means Significance 
A and AF 7.55 not significant 
P and PF 3.25 not significant 
H and HF 4.56 * significant (P<0.01) 
C and CF 5.05 not significant 
C and A 3.14 not significant 
C and AF 4.41 not significant 
C and P 1.75 not significant 
C and PF 5.01 not significant 
C and H 16.75 * significant (P<0.001) 
C and HF 12.19 * significant (P<0.001) 
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pup removal animals (47.62 mg) was not significantly different from 
MG-RNA of adrenalectomized and pup removal animals that did not receive 
F treatment. MG-RNA of F treated hypophysectomized animals (42.61 mg) 
was significantly greater (P<0.01) than MG-RNA of hypophysectomized 
animals that did not receive F treatment, but was still lower (P<0.001) 
than MG-RNA of sham operated controls. 
RNA to DNA ratio (Tables 8 and 10, Fig. 9) 
The RNA to DNA ratios in the mammary gland (MG-RNA:DNA) of 
adrenalectomized animals (1.91) and hypophysectomized animals (1.56) 
were significantly lower (P<0.05 and P<0.001) than the MG-RNA:DNA of 
controls (2.27). The MG-RNA:DNA of pup removal animals (2.13) was not 
significantly different from that of the controls. MG-RNA:DNA's of F 
treated adrenalectomized animals (2.25), F treated pup removal animals 
(2.33) and F treated hypophysectomized animals (1.78) were significantly 
greater (P<0.05) than the MG-RNA:DNA's of similarly operated animals 
that did not receive F treatment. In the case of the F treated 
adrenalectomized animal, the MG-RNA:DNA was increased to the control 
level. In the F treated hypophysectomized animal the MG:RNA:DNA was 
lower (P<0.001) than that of the control. 
Pup Number, Pup Weights and Placental Weights 
The average litter sizes of all treatment groups were comparable 
to each other (Tables 11 and 12). Pup number ranged from 8.7 to 10.2, 
and no significant differences were obtained from any of the planned 
comparisons. 
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Table 10. Statistical comparisons of the RNA to DNA ratios using 
t-test 
Groups Di fference 
compared between means Significance 
A and AF 0.34 * approaches 
significance (P<0.05) 
P and PF 0.20 * approaches 
significance (P<0.05) 
H and HF 0.22 * significant (P<0.05) 
C and CF 0.21 not significant 
C and A 0.36 * significant (P<0.05) 
C and AF 0.02 not significant 
C and P 0.14 not significant 
C and PF 0.06 not significant 
C and H 0.71 * significant (P<0.001) 
C and HF 0.49 * significant (P<0.01) 
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Table 11. Effect of adrenalectomy, pup removal, hypophysectomy and 
hydrocortisone acetate on pup number, unit pup weight 
and unit placental weight 
Group (#) 
# of 
pups s.e. 
Unit pup 
weight 
(g) s.e. 
Unit 
placental 
weight (g) s.e. 
A (9) 10.4 0.9 5.45* 0.20 0.70 0.02 
AF (10) 10.4 0.6 5.77* 0.12 0.67 0.02 
P (9) 8.8 0.8 0.88^ 0.03 0.49 0.05 
PF (9) 8.9 0.7 0.90^ 0.03 0.51 0.02 
H (10) 10.0 0.7 5.47* 0.25 0.69 0.03 
HF (9) 10.2 0.8 5.05* 0.21 0.68 0.03 
C (10) 9.9 0.7 5.66* 0.10 0.68 0.03 
CF (10) 8.7 0.6 5.60* 0.11 0.72 0.03 
*Pup weight on day 22. 
Pup weight on day 18 
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Table 12. Statistical comparisons of litter size using t-test 
Groups Difference 
compared between means Significance 
A and AF 0.0 not significant 
H and HF 0.2 not significant 
C and CF 1.2 not significant 
C and A 0.5 not significant 
C and AF 0.5 not significant 
C and P® 1.1 not significant 
C and H 0.1 not significant 
C and HF 0.3 not significant 
and P a comparison between the number of pups on day 18 and 
day 22. 
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Individual body weights of pups (Tables 11 and 13) from 
adrenalectomized dams (5.45 g), F treated adrenalectomized dams (5.77 g), 
and hypophysectomized dams (5.47 g) were similar to body weights of 
pups from control animals (5.66 g). Body weights of pups from F 
treated hypophysectomized dams (5.05 g) were significantly lower 
(P<0.02) than body weights of pups from control animals. In the case 
of adrenalectomized and sham operated control animals, F treatment did 
not effect a decrease in pup body weight. 
Individual placental weights (Tables 11 and 14) of adrenalectomized 
dams (0.70 g), F treated adrenalectomized dams (0.67 g), hypophysectomized 
dams (0.68 g), F treated hypophysectomized dams (0.68 g), and F treated 
sham operated dams (0.72) were all similar to individual placental 
weights of the sham operated control that did not receive F treatment 
(0.68 g). Individual placental weights of pup removal animals (0.49 g) 
and F treated pup removal animals (0.51) were significantly lower 
(P<0.01 and P<0.001, respectively) than individual placental weights of 
controls (0.68 g). 
Adrenal and Ovarian weights 
Adrenal weights (Tables 15 and 16, Fig. 10) 
Adrenal gland weights on day 18 of pregnancy (75.38 mg) were not 
significantly different from adrenal gland weights of control animals 
on day 22 of pregnancy (72.34). Adrenal gland weights of hypophysecto­
mized animals (55.30 mg) were significantly lighter (P<0.001) than 
adrenal gland weights of controls on day 22 of pregnancy (72.34 mg). 
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Table 13. Statistical comparisons of individual pup weight using t-test 
Groups Di fference 
compared between means Significance 
A and AF 0.32 not significant 
H and HF 0.42 not significant 
C and CF 0.06 not significant 
C and A 0.21 not significant 
C and AF 0.11 not significant 
C and P® 4.78 * significant (P<0.001) 
C and H 0.19 not significant 
C and HF 0.61 * significant (P<0.02) 
and P = a comparison between the pup weight on day 18 and day 22. 
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Table 14. Statistical comparisons of individual placental size using 
t-test 
Groups Difference 
compared between means Significance 
A and AF 0.03 not significant 
P and PF 0.02 not significant 
H and HF 0.01 not significant 
C and CF 0.03 not significant 
C and A 0.02 not significant 
C and AF 0 01 not significant 
C and P 0.19 * significant (P<0.01) 
C and PF 0.17 * significant (P<0.001) 
C and H 0.01 not significant 
C and HF 0.00 not significant 
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Table 15. Effect of adrenalectomy, pup removal, hypophysectomy and 
hydrocortisone acetate on adrenal and ovarian weights 
Group (#) 
Adrenal gland 
weight (mg) s.e. 
Ovari an 
weight (mg) s.e. 
A (9) 75.38* 3.08 142.64 5.18 
AF (10) 72.62* 3.46 143.72 5.91 
P (9) 98.96^ 4.16 159.21 6.27 
PF (9) 86.69^ 3.64 154.64 6.11 
H (10) 56.34b 1.72 127.96 4.86 
HF (9) 55.30" 3.46 136.68 7.72 
C (10) 72.34b 2.35 156.52 8.68 
CF (IG) 66.30^ 3.16 138.43 8.56 
^Adrenal weight on day 18. 
^Adrenal weight on day 22. 
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Table 16. Statistical comparisons of adrenal gland weights expressed 
in mg using t-test 
Groups 
compared 
Difference 
between means Significance 
P and PF 12.27 * significant {P<0.05) 
H and HF 1.04 not significant 
C and CF 6.04 not significant 
C and 3.04 not significant 
C and P 26.62 * significant (P<0.001) 
C and PF 14.35 * significant (P<0.01) 
C and H 16.00 * significant (P<0.001) 
C and HF 17.04 * significant (P<0.001) 
and A = comparison between adrenal weights on day 18 and day 22. 
-n 
ADRENAL GLAND WEIGHT (mg)  
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Adrenal gland weights of pup removal animals (98.96 mg) and F treated 
pup removal animals (86.69 mg) were greater (P<0.001 and P<0.01, 
respectively) than those of the control animals on day 22 of pregnancy 
(72.34 mg). F treatment of pup removal animals resulted in adrenal 
gland weights (86.69 mg) which were significantly lower (P<0.05) than 
adrenal gland weights of pup removal animals that did not receive F 
treatment (98.96 mg). The difference between adrenal gland weights 
of F treated sham operated controls (66.30 mg) and sham operated controls 
that did not receive F treatment (72.34 mg) was not statistically signifi­
cant at the 0.05 level, but may have been biologically significant. 
Ovarian weights (Table 15 and 17, Fig. 11) 
Ovarian weights of adrenalectomized animals (142.64 mg), F treated 
adrenalectomized animals (143.72 mg), pup ronoval animals (159.21 mg), 
F treated pup removal animals (154.64 mg) and F treated sham operated 
control animals (138.43 mg) were not significantly different from 
ovarian weights of sham operated control animals that did not receive 
F treatment (156.52 mg). Ovarian weights of hypophysectomized animals 
(127.96 mg) were significantly lower (P<0.01) than ovarian weights of 
controls (156.25 mg). The difference between ovarian weights of F 
treated hypophysectomized animals (136.68 mg) and controls (156.52 mg) 
was not statistically significant, but may have been biologically 
significant. 
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Table 17. Statistical comparisons of total ovarian weight expressed 
in mg using t-test 
Groups Difference 
compared between means Significance 
A and AF 1.08 not significant 
P and PF 4.57 not significant 
H and HF 8.72 not significant 
C and CF 18.09 not significant 
C and A 13.88 not significant 
C and AF 12.80 not significant 
C and P 2.59 not significant 
C and PF 1.88 not significant 
C and H 28.56 * significant (P<0.01) 
C and HF 19.84 not significant 
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Adrenal secretion rates (Tables 18-22, Fig. 12) 
In vitro adrenal corticosterone secretion rates (expressed as ug 
corticosterone/100 mg adrenal/hr) of 18 day controls (3,92) and pup 
removal animals (3.50) were not significantly different from those of 
22 day controls (4.46). Similarly, ACTH stimulated adrenal corti-
costerone secretion rates of 18 day controls (9.42) and pup removal 
animals (7.44) were not significantly different from ACTH stimulated 
adrenal corticosterone secretion rates of 22 day controls (12.79). 
The differences between non-stimulated and ACTH stimulated adrenal 
corticosterone secretion rates within each group (18 day control, 22 
day control and pup removal) were statistically significant at the 
0.001, 0.005 and 0.005 levels, respectively. 
Plasma corticosterone levels (Tables 23 and 24, Fig. 13) 
Plasma corticosterone levels (expressed as yg corticosterone/100 
ml plasma) of 18 day controls (41.16) and pup removal animals (30.72) 
were not significantly different from the levels of 22 day control 
animals (42.66). Plasma corticosterone levels of adrenalectomized 
animals (17.17) were significantly lower (P<0.005) than levels of 22 
day control animals (42.66). 
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Table 18. In vitro adrenal corticosterone secretion rates of 
eighteen day controls, twenty-two day controls, and 
pup removal animals 
Group (#) yg corticosterone/100 mg adrenal/hr s.e. 
U • UV E (10) 3.92 
C (8) 4.46 0.78 
P (7) 3.50 0.50 
Table 19. Effect of ACTH on in vitro adrenal corticosterone 
secretion rates of eighteen day controls, twenty-two 
day controls, and pup removal animals 
Group (#) ug corticosterone/100 mg adrenal/hr s.e. 
E (10) 9.24 1.22 
C (8) 12.79 2.24 
P (7) 7.44 0.78 
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Table 20. Statistical comparisons of in vitro adrenal corticosterone 
secretion rates 
Groups Difference 
Compared between means Significance 
E and C 0.54 not significant 
P and C 0.96 not significant 
Table 21. Statistical comparisons of ACTH stimulated in vitro adrenal 
corticosterone secretion rates 
Groups 
Compared 
Difference 
between means Significance 
E and C 3.37 not significant 
P and C 5.35 not significant 
Table 22. Statistical comparisons of ACTH 
adrenal corticosterone secretion 
stimulated and non-stimulated 
rates 
Groups 
Compared 
Difference 
between means Significance 
E(-ACTH) and E(+ACTH) 5.50 * significant (P<0.001) 
C(-ACTH) and C(+ACTH) 8.32 * significant (P<0.005) 
P(-ACTH) and P(+ACTH) 3.94 * significant (P<0.005) 
64 
ACTHi 
+ ACTH 15 
k 3 O 
^ 10 
o 
c 
«  
•o 
o 
a* 
E 
o 
o 
o 
c 
2 
« 
c w 
8 
GROUP 
Fig. 12. In vitro adrenal corticosterone secretion rates 
65 
Table 23. Plasma corticosterone levels in eighteen day controls, 
twenty-two day controls, pup removal animals and 
adrenalectomized animals 
uq corticosterone 
Group (#) 100 ml plasma s.e. 
E (11) 41.16 6.45 
C (10) 42.66 5.58 
P (7) 30.72 10.04 
A (10) 17.17 3.56 
Table 24. Statistical comparisons of plasma corticosterone levels 
Groups Difference 
Compared between means Significance 
E and C 1.50 not significant 
P and C 11.94 not significant 
A and C 25.49 * significant (P<0.005) 
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DISCUSSION 
It has been suggested (Banerjee et al., 1971) that RNA synthesis 
in the mammary gland is selectively more dependent upon adrenocortical 
hormones during its functional, rather than structural, development, 
and that DNA synthesis (indicative of cellular proliferation) is not 
affected by adrenocortical hormones during late pregnancy (Ferreri 
and Griffith, 1969). The results of this investigation agree with 
these earlier works. Adrenalectomy on day 18 of pregnancy resulted in 
a decrease in the RNA to DNA ratio in the gland, a decrease in 
individual cell size and a decrease in the overall size of the mammary 
gland. However, it had no effect on total mammary gland DNA, indicating 
that cell number was not affected. Treatment of adrenalectomized 
animals with hydrocortisone acetate restored the RNA to DNA ratio, 
individual cell size and overall gland size to normal, but did not 
effect an increase in total mammary gland DNA. 
George et al. (1973) hypophysectomized rats on day 14 of pregnancy 
and reported a significant decrease in total mammary gland DNA and 
total mammary gland RNA, and found no difference between the RNA: 
DNA ratios of hypophysectomized animals and 20 day controls. In this 
study, mammary glands from animals hypophysectomized on day 18 and 
sacrificed on day 22 contained almost as much DNA as controls, but 
contained far less RNA. The RNA to DNA ratios of these hypophysectomized 
animals were significantly lower than those of controls. Treatment of 
hypophysectomized animals with hydrocortisone acetate resulted in an 
increase in total RNA and the RNA to DNA ratio, but did not restore 
these to the control levels. As stated previously, mammary gland 
development during pregnancy can be divided into two phases; 
mammogenesis and lactogenesis. In the study by George et al. (1973) 
the cessation of cellular proliferation implicates anterior pituitary 
hormones in mammogenesis during mid-pregnancy. The lower day 22 mammary 
gland RNA to DNA ratios of animals hypophysectomized on day 18 implicates 
anterior pituitary hormones in the pre-partum phase of lactogenesis. 
Chadwick (1971) has reported that ACTH, given systemically, induces 
lactogenesis in pseudopregnant rabbits and that the ACTH effect is 
mediated by corticosteroid secretion. In this study, adrenal glands 
of rats hypophysectomized on day 18 were significantly lighter than 
adrenal glands of controls. Treatment of hypophysectomized animals 
with hydrocortisone acetate resulted in an increase in the RNA to DNA 
ratio, and supports Chadwick's conclusions concerning the role of ACTH. 
However5 the RNA to DNA ratios of hydrocortisone treated hypophysectomized 
animals were still significantly lower than those of controls; suggesting 
that pituitary hormones, in addition to ACTH, are required for normal 
lactogenesis. Meites and Turner (1947) have reported that prolactin 
alone can induce lactation in pregnant rabbits and it has been suggested 
(Meites, 1954) that prolactin is an essential component of a lactogenic 
hormonal complex. Ben-David et al. (1971) and Chadwick (1971) have 
described a synergistic action of prolactin and adrenocortical hormones 
on mammary gland development in. vivo- El-Darwish and Rivera (1970) 
have described the optimum requirements for RNA synthesis by pregnant 
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mouse mammary glands cultured in vitro as being insulin, prolactin 
and corticosterone. The inability of treatment of hypophysectomized 
animals with hydrocortisone acetate to restore total RNA and the RNA 
to DNA ratio to normal may reflect the absence of pituitary prolactin. 
Desjardins et al. (1968) reported that removal of the fetus 
after mid-pregnancy (day 12) did not interfere with mammary gland 
DNA and RNA. In this investigation, pups were removed on day 18 and 
mammary gland DNA and RNA values were similar to the 22 day control 
values. Treatment of pup removal animals with hydrocortisone acetate 
had no effect on mammary gland DNA and RNA. 
One of the aims of this investigation was to determine whether 
the onset of fetal adrenal activity could be considered a triggering 
mechanism for the initiation of milk secretion in the rat. The results 
obtained suggest that a fetal contribution to the level of circulating 
glucocorticoids is not essential for lactogenesis, but that sustained 
maternal adrenal activity is essential. 
Plasma corticosterone levels of pup removal animals were similar 
to those of 22 day control animals. Mammary gland size, DNA content 
and the RNA to DNA ratio of pup removal animals were also similar 
to 22 day control values. In the initial stages of this investigation, 
an increase in adrenal gland weights of pup removal animals was noted, 
and suggested a compensatory hypertrophy of the maternal adrenal in 
the absence of the fetus. However, evidence to refute this observation 
was subsequently obtained. An increase in adrenal gland weights was 
not noted in a second group of pup removal animals,and in vitro 
adrenal corticosterone secretion rates of pup removal animals were found 
to be similar to those of 22 day controls. ACTH stimulated adrenals of 
pup removal animals produced a significantly greater amount of 
corticosterone in vitro than non-stimulated adrenals of pup removal 
animals, again suggesting that the adrenal glands were not being maximally 
stimulated in vivo. 
The essentiality of sustained maternal adrenal activity in 
lactogenesis, and the inability of fetal adrenal hypertrophy to 
compensate for the lack of adrenal steroids following adrenalectomy 
also was demonstrated in this study. Plasma corticosterone levels of 
adrenalectomized dams were significantly lower than levels of 22 day 
control animals. Mammary gland weights and the RNA to DNA ratios of 
adrenalectomized animals were smaller than those of the 22 day controls. 
The possibility that increased maternal glucocorticoid secretion 
near term could serve as the triggering mechanism for the initiation 
of milk secretion ms also considered. Plasma corticosterone and in 
vitro adrenal corticosterone secretion rates of 18 day controls were 
similar to those of 22 day controls, indicating that an increase in 
maternal glucocorticoid secretion is not necessary. Other workers have 
suggested that sensitivity to glucocorticoids, rather than secretion 
rates, may change near term. Gala and Westphal (1965) have reported 
that during most of pregnancy, the level of biologically active 
glucocorticoids may be low because of increased binding to corticoid 
binding globulin (CBG), but that during late pregnancy, the level of 
biologically active glucocorticoids increases as a result of decreased 
binding to CBG. Curry and Beaton (1958) have reported that pregnant 
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rats exhibit a marked resistance to the biological effects of the 
administration of cortisone, and that this resistance may be imparted 
by placental hormones. With particular reference to the mammary gland, 
Ferreri and Griffith (1959) have reported that treatment of pregnant 
rats with hydrocortisone acetate during early pregnancy has no effect 
on the mammary gland RNA to DNA ratio, whereas treatment during late 
pregnancy results in an increase in the RNA to DNA ratio. Therefore, 
an increase in mammary gland sensitivity to lactogenic stimulation 
by glucocorticoids and an increase in the level of biologically active 
glucocorticoids near term may be considered the mechanism which 
triggers the increase in the mammary gland RNA to DNA ratio at the 
time of lactogenesis, rather than an increase in maternal adrenal 
secretion rates. 
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SUMMARY 
The present investigation was concerned with the effect of 
adrenalectomy, pup removal, hypophysectomy and treatment with 
hydrocortisone acetate on mammary gland nucleic acid content near 
term in the rat. It was designed to allow for a consideration of the 
onset of fetal adrenal activity or changes in maternal adrenal 
activity as a possible triggering mechanism for lactogenesis. Surgery 
was performed on day 18 of pregnancy; hydrocortisone treated animals 
were injected from day 18 to day 21; and animals (excluding the 18 
day controls) were sacrificed on day 22. Mammary gland nucleic acid 
content was estimated colorimetrically and used to assess the extent 
of mammary gland development. Adrenal glands from 18 day controls, 
pup removal animals and 22 day controls were incubated for 90 minutes 
with or without ACTH stimulation. In vitro adrenal corticosterone 
secretion rates were estimated fluorometrically and used to assess 
adrenal gland function in vivo. Plasma corticosterone levels of 18 
day controls, adrenalectomized animals, pup removal animals and 22 day 
controls were also estimated fluorometrically. 
The results reported herein indicated the following: 
1= Glucocorticoids are involved in the increase in the RNA to 
DNA ratio, individual cell size and overall gland size which occurs 
near term. Adrenalectomy abolishes these increases. Treatment of 
adrenalectomized animals with hydrocortisone acetate restores these 
values to normal. 
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2. Pituitary hormones, in addition to ACTH, are involved in the 
increase in the RNA to DNA ratio, individual cell size and overall 
gland size which occurs near term. Hypophysectomy abolishes these 
increases. Treatment of hypophysectomized animals with hydrocortisone 
acetate does not completely restore these values to normal. 
3. A fetal contribution to the level of circulating glucocorticoids 
is not essential for lactogenesis. Pup removal has no effect on plasma 
corticosterone levels, in vitro adrenal corticosterone secretion rates, 
or mammary gland nucleic acid content. 
4. Sustained maternal adrenal activity is essential for lacto­
genesis and the effects of adrenalectomy cannot by fully compensated 
for by fetal adrenal hypertrophy. Plasma corticosterone levels of 
adrenalectomized animals are significantly lower than plasma corti­
costerone levels of controls. 
5. An increase in marmary gland sensitivity to lactogenic 
stimulation by the glucocorticoids and/or an increase in the level 
of biologically active glucocorticoids is probably involved in effecting 
mammary gland differentiation near term. An actual increase in 
maternal adrenal glucocorticoid secretion apparently does not occur. 
Plasma corticosterone levels and in vitro adrenal corticosterone 
secretion rates of 18 day control animals were not significantly 
different from those of 22 day controls. 
74 
LITERATURE CITED 
Ahren, K., and D. Jacobson. 1957. The action of cortisone on the 
mammary glands of rats under various states of hormonal imbalance. 
Acta Physiologica Scandinavica 40:254-272. 
Alexander, P., H. G. Britton, M. L. Forsling, D. A. Nixon, and J. C. 
Ratcliff. 1971. The concentration of adrenocorticotrophin, vaso­
pressin and oxytocin in the foetal and maternal plasma of the sheep 
in the latter half of gestation. Journal of Endocrinology 49: 
179-180. 
Alexander, P., H. G. Britton, V. H. T. James, D. A. Nixon, R. A. Parker, 
M. E. Wintaur, and R. D. Wright. 1968. Steroid secretion by the 
adrenal gland of foetal and neonatal sheep. Journal of Endocrinology 
40:1-13. 
Anderson, A. B. M., C. G. Pierrepoint, A. C. Turnbull, and K. Griffiths. 
1973. Steroid investigations in the developing sheep foetus. 
Pages 23-39 iji C. G. Pierrepoint, ed. The endocrinology of 
pregnancy and parturition. Alpha Omega Alpha Publishing College 
Buildings, Cardiff, Wales. 
Anderson, L. L., K. P. Bland, and R. M. Melampy. 1969. Comparative 
aspects of uterine-luteal relationships. Recent Progress in Hormone 
Research 25:57-104. 
Baldwin, R. L., and L. P. Milligan. 1966. Enzymatic changes associated 
with the initiation and maintenance of lactation in the rat. 
Journal of Biological Chemistry 241:2058-2066. 
Banerjee, M. R., and D. N. Banerjee. 1971. Hormonal regulation of RNA 
synthesis and membrane ultra-structure in mouse mammary gland. 
Experimental Cell Research 64:307-316. 
Banerjee, M. R., F. M. Rogers, and D. N. Banerjee. 1971. Hormonal 
regulation of RNA and protein synthesis in the mouse mammary gland 
before and during lactation. Journal of Endocrinology 50:281-291. 
Basset, J. M., and G. D. Thorburn. 1969. Foetal plasma corticosteroids 
and the initiation of parturition in sheep. Journal of 
Endocrinology 44:285-286. 
Basset, J. M., and G. D. Thorburn. 1973. Circulating levels of 
progesterone and corticosteroids in the pregnant ewe and its fetus. 
Pages 126-140 ijn C. G. Pierrepoint, ed. The endocrinology of 
pregnancy and parturition. Alpha Omega Alpha Publishing College 
Buildings, Cardiff, Wales. 
75 
Bast, J., and R. M. Melampy. 1972. Luteinizing hormone, prolactin and 
ovarian 20a hydroxysteroid dehydrogense levels during pregnancy 
and pseudopregnancy in the rat. Endocrinology 91:1499-1505. 
Ben-David, M., A. Danon, R. Benveniste, C. P. Weller, and F. 6. Sulman. 
1971. Results of radioimmunoassays of rat pituitary and serum 
prolactin after adrenalectomy and perphenazine treatment in rats. 
Journal of Endocrinology 50:599-606. 
Bloch, E. 1968. Fetal adrenal cortex: Function and steroidogenesis. 
Pages 721-774 jjn K. W. McKerns, ed. Functions of the adrenal cortex. 
Vol. 2. Appleton, Century, Crofts, New York, N.Y. 
Bruce, J. 0., and V. D. Ramirez. 1970. Site of the inhibitory effect 
of estrogen upon lactation. Neuroendocrinology 6:19-29. 
Burton, K. 1956. A study of the conditions and mechanisms of the 
diphenylamine reaction for the colorimetric estimation of 
desoxyribonucleic acid. Biochemistry Journal 62:315-322. 
Ceriani, R. L. 1974. Hormones and other factors controlling growth in 
the mammary gland: A review. Journal of Investigative Dermatology 
63:93-108. 
Chadwick, A. 1971. Lactogenesis in pseudopregnant rabbits treated 
with adrenocorticotrophin and adrenal corticosteroids. Journal 
of Endocrinology 49:1-8. 
Chan, S. W. C., and J. H. Leathem. 1975. Placental steroidogenesis 
in the rat: progesterone production by tissues of the basal zone. 
Endocrinology 96:298-303. 
Christianson, M., and I. Chester Jones. 1957. The interrelationships 
of the adrenal glands of mother and foetus in the rat. Journal of 
Endocrinology 15:17-42. 
Cohen, A. 1973. Plasma corticosterone concentration in the fetal rat. 
Hormone and Metabolic Research 5:66. 
Cohen, P. P. 1957. Suspending medium for animal tissues. Pages 147-150 
2n W. W. Umbreit, R. H. Burris, and J. F. Stauffer, eds. 
Manometric Techniques. Third edition. Burgess Publishing Co., 
Minneapolis, Minn. 
Cowie, A. T. 1949. The relative growth of mammary gland in normal 
and gonadectomized and adrenalectomized rats. Journal of 
Endocrinology 6:145-157. 
76 
Cowie, A. T. 1969. General hormonal factors involved in lactogenesis. 
Pages 157-170 M. Reynolds and S. J. Fol ley, eds. Lactogenesis: 
The initiation of milk secretion at parturition. University of 
Pennsylvania Press, Philadelphia, Pa. 
Craig, B. W. 1972. Effects of exercise, thyroxine, and age on corti-
costerone production in the male rat. Unpublished Ph.D. Thesis. 
Iowa State University of Science and Technology, Ames, Iowa. 
Currie, W. B., M. S. F. Wong, R. I. Cox, and G. D. Thorburn. 1973. 
Spontaneous or dexamethasone-induced parturition in the sheep and 
goat: changes in plasma concentrations of maternal prostaglandin 
F and foetal oestrogen sulfate. Pages 95-118 iji A. Klopper and 
J. Gardner, eds. Endocrine factors in labour. Memoirs of the 
Society for Endocrinology No. 20. Cambridge University Press, 
Cambridge. 
Curry, D. M. and G. H. Beaton. 1958. Cortisone resistance in pregnant 
rats. Endocrinology 63:155-161. 
Davis, J. W., and T. M. Liu. 1969. The adrenal gland and lactogenesis. 
Endocrinology 85:155-160. 
Davis, J. W., J. Wikman-Coffelt, and C. L. Eddington. 1972. The effect 
of progesterone on biosynthetic pathways in mammary tissue. 
Endocrinology 91:1011-1019. 
Davis, M. E., and E. J. Plotz. 1954. The effect of cortisone acetate 
on intact and adrenalectomized rats during pregnancy. 
Endocrinology 54:384-395. 
Dawes, G. S. 1973. Foetal physiology and the onset of labour. Pages 
25-36 in_A. Klopper and J. Gardner, eds. Endocrine factors in 
labour. Memoirs of the Society for Endocrinology No. 20. Cambridge 
University Press, Cambridge. 
Denamur, R. 1969. Changes in the ribonucleic acids of mammary cells at 
lactogenesis. Pages 53-64 iji M. Reynolds and S. J. Folley, eds. 
Lactogenesis: the initiation of milk secretion at parturition. 
University of Pennsylvania Press, Philadelphia, Pa. 
Denamur, R. 1971. Hormonal control of lactogenesis. Journal of Dairy 
Research 38:237-264. 
Desjardins, C., M. J. Paape, and H. A. Tucker. 1968. Contribution of 
pregnancy, fetuses, fetal placentas and deciduomata to mammary 
gland and uterine development. Endocrinology 83:907-910. 
Dilley, W. G. 1971. Relationship of mitosis to alveolar development 
in rat mammary gland. Journal of Endocrinology 50:501-505. 
77 
Drost, M., and L. W. Holm. 1968. Prolonged gestation in ewes after 
fetal adrenalectomy. Journal of Endocrinology 40:293-296. 
Drost, M., L. F. Kumagai, and M. Guzman. 1973. Sequential foetal-
maternal plasma Cortisol levels in sheep. Journal of Endocrinology 
56:483-492. 
Dvorak, M. 1972. Adrenocortical function in foetal, neonatal and young 
pigs. Journal of Endocrinology 54:473-481. 
el-Darwish, I., and E. M. Rivera. 1970. Hormonal regulation of RNA 
synthesis by mouse mammary gland in vitro. Journal of Experimental 
Zoology 177:295-299. 
Fajer, A. B., and C. A. Barraclough. 1967. Ovarian secretion of 
progesterone and 20a hydroxypregn-4en-3one during pseudopregnancy 
and pregnancy in rats. Endocrinology 81:617-622. 
Ferreri, L. F. 1971. Experimental lactogenesis: role of pituitary, 
adrenal, and ovarian hormones in initiating milk secretion in rats. 
Unpublished Ph.D. Thesis. Iowa State University of Science 
and Technology, Ames, Iowa. 
Ferreri. L, F., and D. R. Griffith. 1969. Effect of hydrocortisone 
acetate on mammary gland nucleic acid content of pregnant rats. 
Society for Experimental Biology and Medicine Proceedings 130: 
1216-1218. 
Ford, J. J., and K. Yoshinaga. 1975a. The role of prolactin in the 
luteotrophic process of lactating rats. Endocrinology 96:329-334. 
Ford, J. J., and K. Yoshinaga. 1975b. The role of LH in the luteo­
trophic process of lactating rats. Endocrinology 96:329-334. 
Gala, R. R. and U. Westphal. 1965. Corticosteroid binding globulin 
in the rat. Possible role in the initiation of lactation. 
Endocrinology 76:1079-1088. 
George, F. W., S. Quarrie, and D. R. Griffith. 1973. Effect of hypo-
physectomy during late pregnancy upon mammary gland growth in the 
rat. Society for Experimental Biology and Medicine Proceedings 
144:647-650. 
Gibori, 6., I. Rothchild, G- J. Pepe, W. K. Morishige, and P. Lam. 
1974. Luteotrophic action of decidual tissue in the rat. 
Endocrinology 95:1113-1118. 
Griffith, D. R., and C. W. Turner. 1957. Desoxyribonucleic acid (DNA) 
content of the mammary gland during pregnancy and lactation. 
Society for Experimental Biology and Medicine Proceedinas 95: 
347-348. 
78 
Griffith, D. R., and C. W. Turner. 1961. Normal growth of rat mammary 
glands during pregnancy and early lactation. Society for 
Experimental Biology and Medicine Proceedings 106:448-450. 
Harkness, M. L. R., and R. D. Harkness. 1956. The effect of pregnancy 
and lactation on the collagen content of the mammary gland of the 
rat. Journal of Physiology 132:476-481. 
Holmann, K. H., and J. M. Verley. 1971. Morphology of secretion in 
mammary gland cells. Pages 31-40 jn I- R- Falcolner, ed. Lactation. 
Pennsylvania State University Press, London. 
Jackson, B. T., H. F. G. Rauschecker, and G. J. Piasecki. 1973. 
Quantitative relations of fetal and maternal pituitary-adrenal 
systems. The Journal of Clinical Investigation 52:3154-3160. 
Jones, C. T. 1974. Corticosteroid concentrations in the plasma of fetal 
and maternal guinea pigs during gestation. Endocrinology 95: 
1129-1133. 
Jones, J. M., C. W. Lloyd, and T. C. Wyatt. 1953. A study of the inter­
relationships of maternal and fetal adrenal glands of rats. 
Endocrinology 53:182-191. 
Jost, A. 1966. Problems of fetal endocrinology: the adrenal glands. 
Recent Progress in Hormone Research 22:541-574. 
Knobil, E., and F. N. Briggs. 1955. Fetal-maternal endocrine inter­
relations: the hypophyseal-adrenal system. Endocrinology 57:147-152. 
Kohmotc, K., and H. Bern. 1970. Demonstration of mammotrophic activity 
of the mouse placenta in organ culture and by transplantation. 
Journal of Endocrinology 48:99-107. 
Kuhn, N. J. 1971. Control of lactogenesis and lactose biosynthesis. 
Pages 161-175 in^ I. R. Falcolner, ed. Lactation. Pennsylvania 
State University Press, London. 
Kuhn, N. J. 1972. Changes in the protein phosphorus content of rat 
mammary tissue during lactogenesis. Journal of Endocrinology 
55:219-220. 
Kumaresan, P., R. R. Anderson, and C. W. Turner. 1967. Effect of 
corticosterone upon mammary gland growth of pregnant rats. 
Endocrinology 81:658-661. 
Labhsetwar, A. P. 1972. Effects of prostaglandins Fg on some repro­
ductive processes of hamsters and rats. Journal of Endocrinology 
53:201-213. 
79 
Labhsetwar, A. P., and D. J. Watson. 1974. Temporal relationships 
between secretory patterns of gonadotrophins, estrogens, 
progestins and prostaglandins-F in periparturient rats. Biology 
of Reproduction 10:103-110. 
Liggins, G. C. 1968. Premature parturition after infusion of corti-
cotrophin or Cortisol into foetal lambs. Journal of Endocrinology 
42:323-329. 
Liggins, G. C. 1969. Premature delivery of foetal lambs infused with 
glucocorticoids. Journal of Endocrinology 45:515-523. 
Liggins, G. C. 1973. Hormonal interactions in the mechanism of 
parturition. Pages 119-140 in A. Klopper and J. Gardner, eds. 
Endocrine factors in labour. Memoirs of the Society for 
Endocrinology No. 20. Cambridge University Press, Cambridge. 
Liggins, G, C., R. J. Fairclough, S. A. Grieves, J. Z. Kendall, and 
B. S. Knox. 1973. The mechanism of initiation of parturition 
in the ewe. Recent Progress in Hormone Research 29:111-159. 
Majumder, G. C., and R. W. Turkington. 1971. Hormonal regulation of 
protein kinases and adenosine 5' monophosphate binding protein 
in developing mammary gland. Journal of Biological Chemistry 
246:5545-5554. 
Matthies, D. L. 1974. Placental peptide hormones affecting fetal 
nutrition and lactation. Effects of rodent chorionic mammotrophin. 
Pages 297-333 in J. B. Josimovich, M. Reynolds, and E. Cobo, eds. 
Lactogenic hormones, fetal nutrition, and lactation. John Wiley 
and Sons s New York; N.Y. 
Mattingly, D. 1962. A simple fluorometric method for the estimation 
of free 11-hydroxycorticoids in human plasma. Journal of 
Clinical Pathology 15:374-379. 
Meites, J. 1954. Recent studies on the mechanisms controlling the 
initiation of lactation. Revue Canadienne de Biologie 13:359-370. 
Meites, J. 1974. Neuroendocrinology of lactation. Journal of 
Investigative Dermatology 63:119-124. 
Meites, J., and J. T. Sgouris. 1953. Can the ovarian hormones inhibit 
the mammary response to prolactin? Endocrinology 53:17-23. 
MeiteS; J=, and C. W. Turner. 1947. The induction of lactation during • 
pregnancy in rabbits and the specificity of lactogenic hormone. 
American Journal of Physiology 150:394-399. 
80 
Mejbaum, W. 1939. Uber die bestimmung kleiner pentosemengen 
insbesondere in derivaten der adenylsaure. Zeitschrift fur 
Physiologische Chemie 258:117-120. 
Milkovic, K., and S. Milkovic. 1962- Studies of the pituitary 
adrenocortical system in the fetal rat. Endocrinology 71:799-802. 
Milkovic, S., K. Milkovic, and J. Paunovic. 1973. The initiation of 
fetal adrenocorticotrophic activity in the rat. Endocrinology 
92:380-384. 
Mills, E. S., and Y. J. Topper. 1970. Some ultrastructural effects of 
insulin, hydrocortisone and prolactin on mammary gland expiants. 
Journal of Cell Biology 44:310-328. 
Moon, R. C., D. R. Griffith, and C. W. Turner. 1959. Normal and 
experimental growth of mammary glands. Society for Experimental 
Biology and Medicine Proceedings 101:788-790. 
Morishige, W. K., and I. Rothchild. 1974. Temporal aspects of the 
regulation of corpus luteum function by luteinizing hormone, 
prolactin and placental luteotrophin during the first half of 
pregnancy in the rat. Endocrinology 95:260-274. 
Morishige, W. K., G. J. Pepe, and I. Rothchild. 1973. Serum luteinizing 
hormone, prolactin, and progesterone levels during pregnancy in the 
rat. Endocrinology 92:1527-1530. 
Munford, R. E. 1963. Changes in the mammary glands of rats and mice 
during pregnancy, lactation and involution. 1. Histological 
structure. Oournal of Endocrinology 28:1-15. 
Nagasawa, H. and R. Yanai. 1972. Changes in serum prolactin levels 
shortly before and after parturition in rats. Endocrinologica 
Japonica 19:139-143. 
Nagasawa, H., H. Iwahashi, M. Kanzawa, M. Fujimoto, and I. Kuretani. 
1967. Further studies on the relation between area and 
desoxyribonucleic acid content of the mammary gland in mice. 
Endocrinologica Japonica 14:23-26. 
Paape, H. J., and Y. N. Sinha. 1971. Nucleic acid and collagen 
content of mammary glands between 30 and 80 days of age in normal 
and ovariectomized rats and during pregnancy. Journal of Dairy 
Science 54:1068-1074. 
Pepe, G., and I. Rothchild. 1972. The effect of hypophysectomy on 
day 12 of pregnancy on the serum progesterone level and time of 
parturition in the rat. Endocrinology 91:1380-1385. 
81 
Porter, J. C. 1974. Hormonal regulation of breast development and 
activity. Journal of Investigative Dermatology 63:85-92. 
Pritchard, J. J., and A. Huggett. 1947. Experimental foetal death 
in the rat: histological changes in the membrane. Journal of 
Anatomy 81:212-223. 
Pritchett, J. F. 1973. Effects of age, exercise, graded thyroxine levels 
and adrenocortiotiophic hormone upon the in vitro secretion of 
corticosterone in the male rat. Unpublished Ph.D. Thesis. Iowa 
State University of Science and Technology, Ames, Iowa. 
Ray, E. W., S. C. Averill, W. C. Lyons, and R. E. Johnson. 1955. Rat 
placental hormonal activities corresponding to those of pituitary 
mammotrophin. Endocrinology 56:359-373. 
Raynaud, A. 1971. Foetal development of the mammary gland and hormonal 
effects on its morphogenesis. Pages 3-29 in I. R. Falconer, ed. 
Lactation. Pennsylvania State University Press, London. 
Saffran, M., B. Grad, and M. Bayliss. 1952. Production of corticoids 
by rat adrenals in vitro. Endocrinology 50:639-643. 
Schneider, W. C. 1945. Extraction and estimation of desoxypentose 
nucleic acids and of pentose nucleic acids. Journal of Biological 
Chemistry 161:293-303. 
Schneider, W. C. 1957. Determination of nucleic acids in tissues by 
pentose analysis. Pages 680-684 in S. P. Colowick and N. 0. 
Kaplan, eds. Methods in Enzymology, Vol. III. Academic Press, 
New York) N.Y. 
Schwartz, N. B. 1969. A model for the regulation of ovulation in the 
rat. Recent Progress in Hormone Research 25:1-55. 
Selye, H., J. B. Collip, and D. L. Thomson. 1935. Endocrine inter­
relationships during pregnancy. Endocrinology 19:151-159. 
Sherrick, J. C., J. P. Kalteinbach, and J. Huerga. 1971. The chemical 
measurement of serum Cortisol. Pages 481-491 in^ F. W. Sunderman 
and F. W. Sunderman, Jr., eds. Laboratory diagnosis of endocrine 
diseases. Warren H. Green, Inc., St. Louis, Mo. 
Sinha, Y. N., and H. A. Tucker. 1966. Mammary gland growth of rats 
between 10 and 100 days of age. American Journal of Physiology 
210:601-605. 
Smith, I. D., and R. P. Shearman. 1972. The relationship of human 
umbilical arterial and venous plasma levels of corticosteroids to 
gestational age. Journal of Endocrinology 55:211-212. 
82 
Spies, H. G., Y. M. Forbes, and M. T. Clegg. 1971. Influence of 
coitus, suckling and prolactin injections on pregnancy in pelvic 
neurectomized rats. Society for Experimental Biology and Medicine 
Proceedings 138:470-474. 
Stefaniw, A. 1971. Effect of exogenous estrogen and progesterone 
on rat mammary gland development during late pregnancy and early 
lactation. Unpublished Master's Thesis. Iowa State University 
of Science and Technology, Ames, Iowa. 
Takayama, M., and G. S. Greenwald. 1973. Hormonal requirements for the 
maintenance of luteal function in hypophysectomized pseudopregnant 
rats. Journal of Endorcinology 56:421-429. 
Talwalker, P. K., C. S. Nicoll, and 0. Meites. 1961. Induction of 
mammary secretion in pregnant rats and rabbits by hydrocortisone 
acetate. Endocrinology 69:802-808. 
Topper, Y. J. 1970. Multiple hormone interactions in the development 
of mammary gland in vitro. Recent Progress in Hormone Research 
26:287-308. 
Topper, Y. J., and M. Green. 1971. Some effects of prolactin, insulin 
and hydrocortisone on RNA synthesis by mouse mammary gland in vitro. 
Pages 239-247 jn I. R. Falconer, ed. Lactation. Pennsylvania State 
University Press, London. 
Tucker, H. A. 1969. Factors affecting mammary gland cell numbers. 
Journal of Dairy Science 52:721-729. 
Tucker, H. A., and R. P. Reaca. 1952. Nucleic acid estimates of 
mammary tissue and nuclei. Society for Experimental Biology and 
Medicine Proceedings 111:639-642. 
Tucker, H. A., and R. P. Reece. 1963. Nucleic acid content of mammary 
glands of pregnant rats. Society for Experimental Biology and 
Medicine Proceedings 112:370-372. 
Turkington, R. W. 1968. Induction of protein synthesis by placental 
lactogen and prolactin in vitro. Endocrinology 82:575-583. 
Turkington, R. W. 1972. Molecular biological aspects of prolactin. 
Pages 111-127 jji G. E. W. Wolstenholme and J. Knight, eds. 
Lactogenic hormones. Churchill Livingston, London. 
Turkington, R. W., and M. Riddle. 1969. Hormone dependent 
phosphorylation of nuclear proteins during mamary gland 
differentiation in vitro. Journal of Biological Chemistry 
244:6040-6046. 
83 
Turkington, R. W., and M. Riddle. 1970. Hormone dependent formation 
of polyribosomes in mammary cells in vitro. Journal of Biological 
Chemistry 245:5145-5152. 
Turkington, R. W., G. C. Majumder, and M. Riddle. 1971. Inhibition 
of mammary gland differentiation in vitro by 5 Bromo-2' 
deoxyuridine. Journal of Biological Chemistry 246:1814-1819. 
Turkington, R. W., G. C. Majumder, N. Kadohama, J. H. Maclndoe, and W. L. 
Frantz. 1973. Hormonal regulation of gene expression in mammary 
cells. Recent Progress in Hormone Research 29:417-455. 
Turner, C. W. 1970. Hormones stimulating mammary gland growth of the 
rat. Missouri Agricultural Experiment Station Research Bulletin 
977. 60 pp. 
Waynforth, H. B., and D. N. Robertson. 1972. Oestradiol content of 
ovarian venous blood and ovarian tissue in hypophysectomized rats 
during late pregnancy. Journal of Endocrinology 54:79-85. 
Wellings, S. R. 1969. Ultrastructural basis of lactogenesis. Pages 
5-26 in^ M. Reynolds and S. J. Folley, eds. Lactogenesis: The 
initiation of milk secretion at parturition. University of 
Pennsylvania Press, Philadelphia, Pa. 
Wiest, W. 6., W. R. Kidwell, and K. Galogh. 1968. Progesterone 
catabolism in the rat ovary: A regulatory mechanism for proges­
tational potency during pregnancy. Endocrinology 82:844-859. 
Yoshinaga, K., R. A. Hawkins, and J. F. Stocker. 1969. Estrogen 
secretion by the rat ovary in vivo during the estrus cycle and 
pregnancy. Endocrinology 85:103-112. 
Zarrow, M. X., J. M. Yochim, and J. L. McCarthy. 1964. Experimental 
endocrinology: A sourcebook of basic techniques. Academic Press, 
New York, N.Y. 519 pp. 
84 
ACKNOWLEDGMENTS 
I would like to thank Dr. David R. Griffith for his supervision 
of this research problem and for the many years that he has endured 
me. His interest and genuine concern about all of his students has 
engendered by deepest regard and respect. I am indebted to 
Dr. Donald C. Beitz for allowing me to use his virgin spectrophotometer 
and for his reassurance when I needed it most. To Dr. Redmond, I owe 
most of what I know about 95% of the animal kingdom, and I would also 
like to thank him for his suggestions in the writing of this 
dissertation. My gratitude is extended to Dr. Jerry Young for serving 
on my committee and for his excellent classroom instruction. To 
Dr. Robert M. Melampy, I sincerely offer my appreciation for his 
constructive criticism and evaluation. It would be impossible for me 
to enumerate the many ways in which I am indebted to Dr. Yola Forbes. 
She has been a model for me in many ways and has a very special place 
in my thoughts. I have been enriched greatly by my association with 
all of the graduate students in Dr. Griffith's group. Socially and 
academically they are the very finest. To James Severson, I particularly 
acknowledge my appreciation for his help in sacrificing some of the 
animals. Finally, although this dissertation may not be very meaningful, 
in itself, to my mother and sister, their encouragement and faith in me 
has certainly made it possible. 
